Recent News and Updates
Introducing RareValue - A decision model for preclinical and clinical stage investments to help unleash the full treatment and commercialization potential in rare and orphan diseases. RareValue is a robust and repeatable analytic tool for the 7,000 rare and orphan diseases that represent different risk/reward dynamics. This interactive tool assesses the potential of molecules while enabling filtering by therapy type (e.g. gene therapy, cell therapy) and considering regional differences. Click here for more information.
|
Wondering how Covid-19 will affect orphan drug development? Check out our latest blog post, Covid-19 and the Rare Disease Sector to learn about the pandemic's impact on the orphan space.
|